Table 4.
Longitudinal change (12 months—baseline) of blood glucose metabolism and lipid profile
| Variable | Individual intervention (n = 76) | Collective intervention (n = 77) |
p-value |
|---|---|---|---|
| Lipid | |||
| Total cholesterol (mmol/L) | − 0.20 (− 0.35 to − 0.05) | − 0.09 (− 0.004 to 0.18) | 0.056 |
| LDL cholesterol (mmol/L) | − 0.08 (− 0.17 to − 0.001) | − 0.17 (− 0.27 to − 0.07) | 0.359 |
| HDL cholesterol (mmol/L) | 0.03 (− 0.02 to 0.08) | 0.01 (− 0.03 to 0.05) | 0.537 |
| Triglycerides (mmol/L) | − 0.29 (− 0.38 to − 0.20) | − 0.15 (− 0.24 to − 0.03) | 0.036 |
| Apo A1 (g/L) | − 0.002 (− 0.05 to 0.05) | − 0.02 (− 0.10 to 0.06) | 0.512 |
| Apo B (g/L) | − 0.01 (− 0.08 to 0.06) | − 0.03 (− 0.08 to 0.02) | 0.460 |
| AIP | − 0.12 (− 0.16 to − 0.08) | − 0.05 (− 0.10 to 0.005) | 0.013 |
| Glucose metabolism | |||
| Glucose (mmol/L) | − 0.02 (− 0.11 to 0.07) | 0.08 (− 0.002 to 0.16) | 0.156 |
| Insulin (pmol/L) | − 23.06 (− 38.39 to − 7.73) | − 20.35 (− 37.65 to − 3.06) | 0.804 |
| HOMA-IR | − 0.72 (− 1.21 to − 0.22) | − 0.21 (− 0.89 to 0.47) | 0.095 |
| HOMA-β% | − 58.60 (− 92.20 to − 25.00) | − 84.84 (− 142.74 to − 29.44) | 0.390 |
| QUICK index | 0.01 (0.005 to 0.014) | 0.001 (− 0.006 to 0.01) | 0.447 |
| TyG index | − 0.22 (− 0.30 to − 0.14) | − 0.08 (− 0.01 to 0.17) | 0.005 |
Values are mean (95% CI)
LDL low-density-lipoprotein, HDL high-density-lipoprotein, Apo A1 apolipoprotein A1, Apo B apolipoprotein B, AIP atherogenic index of plasma, HOMA-IR homeostatic model assessment of insulin resistance, HOMA-β% homeostatic model assessment of β-cell function, QUICK quantitative insulin sensitivity check, TyG triglyceride-glucose